Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling

por XIAO, JUAN, XU, MANMAN, HOU, TENG, HUANG, YONGWEN, YANG, CHENLU, LI, JUNDONG
Publicado 2015

GANT61 and Valproic Acid Synergistically Inhibited Multiple Myeloma Cell Proliferation via Hedgehog Signaling Pathway

por Zhang, Zhihua, Zhang, Rongjuan, Hao, Changlai, Pei, Xiaochuan, Li, Jundong, Wang, Lihong
Publicado 2020

Spatial-Temporal Networks for Antibiogram Pattern Prediction

por Fu, Xingbo, Chen, Chen, Dong, Yushun, Vullikanti, Anil, Klein, Eili, Madden, Gregory, Li, Jundong
Publicado 2023

Overlapping filter bank convolutional neural network for multisubject multicategory motor imagery brain-computer interface

por Luo, Jing, Li, Jundong, Mao, Qi, Shi, Zhenghao, Liu, Haiqin, Ren, Xiaoyong, Hei, Xinhong
Publicado 2023

miR-149-5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway

por Xu, Manman, Xiao, Juan, Chen, Ming, Yuan, Linjing, Li, Jundong, Shen, Hongwei, Yao, Shuzhong
Publicado 2018

Is Routine Gastroscopy/Colonoscopy Reasonable in Patients With Suspected Ovarian Cancer: A Retrospective Study

por Liu, Guochen, Yan, Junping, Long, Shanshan, Liu, Zhimin, Gu, Haifeng, Tu, Hua, Li, Jundong
Publicado 2021

Clinical study on the feasibility of new thrombus markers in predicting massive cerebral infarction

por Zhao, Xiaoxia, Yang, Siyu, Lei, Ruining, Duan, Qiaoyan, Li, Jundong, Meng, Jiangtao, Sun, Lei
Publicado 2023

Development and External Validation of a Novel Model for Predicting Postsurgical Recurrence and Overall Survival After Cytoreductive R0 Resection of Epithelial Ovarian Cancer

por Li, Qiaqia, Deng, Yinghong, Wei, Wei, Yang, Fan, Lin, An, Yao, Desheng, Zhu, Xiaofeng, Li, Jundong
Publicado 2022

A novel marker integrating multiple genetic alterations better predicts platinum sensitivity in ovarian cancer than HRD score

por Yang, Fan, Wei, Wei, Li, Ganghua, Lan, Qiongyu, Liu, Xiwei, Gao, Lin, Zhang, Chao, Fan, Jiangtao, Li, Jundong
Publicado 2023

Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer: an exploratory imaging biomarker analysis of the AEROC trial

por Huang, Xin, Xie, Chuanbo, Tang, Jie, He, Wenzhuo, Yang, Fan, Tian, Wenfang, Li, Jundong, Yang, Qiuxia, Shen, Jingxian, Xia, Liangping, Lan, Chunyan
Publicado 2020

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy

por Zhou, Yun, Chen, Chang-long, Jiang, Sen-wei, Feng, Yanling, Yuan, Linjing, Chen, Ping, Zhang, Lan, Huang, Shuting, Li, Jundong, Xia, Jian-Chuan, Zheng, Min
Publicado 2018

Emerging highly pathogenic avian influenza (H5N8) virus in migratory birds in Central China, 2020

por Xiong, Jiasong, Zhou, Hao, Fan, Lifang, Zhu, Gongliang, Li, Yong, Chen, Guang, Zhang, Jun, Li, Jundong, Zheng, Hesong, Feng, Wei, Chen, Jing, Yang, Guoxiang, Chen, Quanjiao
Publicado 2021

Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer

por Wei, Wei, Ban, Xiaohua, Yang, Fan, Li, Jibin, Cheng, Xiaqin, Zhang, Rong, Huang, Xin, Huang, Yongwen, Li, Qiaqia, Qiu, Ya, Zheng, Min, Zhu, Xiaofeng, Li, Jundong
Publicado 2022

The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages

por Pan, Baoyue, Wan, Ting, Zhou, Yun, Huang, Shuting, Yuan, Linjing, Jiang, Yinan, Zheng, Xiaojing, Liu, Pingping, Xiang, Huiling, Ju, Mingxiu, Luo, Rongzhen, Jia, Weihua, Lan, ChunYan, Li, Jundong, Zheng, Min
Publicado 2023

A novel combination of niraparib and anlotinib in platinum-resistant ovarian cancer: Efficacy and safety results from the phase II, multi-center ANNIE study

por Liu, Guochen, Feng, Yanling, Li, Jing, Deng, Ting, Yin, Aijun, Yan, Lei, Zheng, Min, Xiong, Ying, Li, Jundong, Huang, Yongwen, Zhang, Chuyao, Huang, He, Wan, Ting, Huang, Qidan, Lin, An, Jiang, Jie, Kong, Beihua, Liu, Jihong
Publicado 2022

Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial

por Lan, Chunyan, Shen, Jingxian, Wang, Yin, Li, Jundong, Liu, Zhimin, He, Mian, Cao, Xinping, Ling, Jiayu, Huang, Jiaming, Zheng, Min, Zou, Guorong, Yan, Haowen, Liu, Qing, Yang, Fan, Wei, Wei, Deng, Yanhong, Xiong, Ying, Huang, Xin
Publicado 2020

RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer

por Deng, Peng, Wang, Zining, Chen, Jinghong, Liu, Shini, Yao, Xiaosai, Liu, Shaoyan, Liu, Lizhen, Yu, Zhaoliang, Huang, Yulin, Xiong, Zhongtang, Xiao, Rong, Gao, Jiuping, Liang, Weiting, Chen, Jieping, Liu, Hui, Hong, Jing Han, Chan, Jason Yongsheng, Guan, Peiyong, Chen, Jianfeng, Wang, Yali, Yin, Jiaxin, Li, Jundong, Zheng, Min, Zhang, Chao, Zhou, Penghui, Kang, Tiebang, Teh, Bin Tean, Yu, Qiang, Zuo, Zhixiang, Jiang, Qingping, Liu, Jihong, Xiong, Ying, Xia, Xiaojun, Tan, Jing
Publicado 2022